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Key points summary 
 Type 1 diabetes mellitus increases cardiovascular risk: hypertension amplifies this risk.  
Pressure natriuresis regulates long-term blood pressure.   
 We induced type 1 diabetes in rats by streptozotocin injection and after three weeks 
demonstrated a substantial impairment of pressure natriuresis: acute increases in blood 
pressure did not increase renal medullary blood flow, and tubular sodium reabsorption was 
not downregulated.  Proximal tubule sodium reabsorption, measured by lithium clearance, 
was unaffected. 
 Insulin reduced blood glucose in diabetic rats, and rescued the pressure natriuresis response 
without influencing lithium clearance.  However, insulin did not restore medullary blood 
flow.  
 On radiotelemetry, diastolic blood pressure was increased in diabetic rats, and its diurnal 
variation was reduced.  
 Increases in medullary blood flow and decreases in distal tubule sodium reabsorption that 
offset acute rises in BP are impaired in early type 1 diabetes.  Their impairment could be a 
target for preventing hypertension in type 1 diabetes. 
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Abstract  
Type 1 diabetes mellitus (T1DM) substantially increases cardiovascular risk, and hypertension 
amplifies this risk. Blood pressure (BP) and body sodium homeostasis are linked.  T1DM patients 
have increased total exchangeable sodium, correlating directly with BP. Pressure natriuresis is an 
important physiological regulator of BP. We hypothesised that pressure natriuresis would be 
impaired, and BP increased, in the early phase of T1DM.  Male Sprague-Dawley rats were injected 
with streptozotocin (30-45mg/kg) or citrate vehicle.  After three weeks, pressure natriuresis was 
induced by serial arterial ligation. In non-diabetic controls, this increased fractional excretion of 
sodium from ~1% to ~25% of the filtered load (P<0.01); in T1DM rats, the response was significantly 
blunted, peaking at only ~3% (P<0.01). Mechanistically, normal lithium clearance suggested that 
distal tubular sodium reabsorption was not downregulated with increased BP in T1DM rats. The 
pressure-dependence of renal medullary perfusion, considered a key factor in the integrated 
response, was abolished. Insulin therapy rescued the natriuretic response in diabetic rats, restoring 
normal downregulation of tubular sodium reabsorption when BP was increased. However, the 
pressure-dependence of medullary perfusion was not restored, suggesting persistent vascular 
dysfunction despite glycaemic control.  On radiotelemetry, T1DM did not affect systolic BP, but 
mean diastolic BP was ~5mmHg higher than in non-diabetic controls (P<0.01), and normal diurnal 
variation was reduced.  In conclusion, functional impairment of renal sodium and BP homeostasis is 
an early manifestation of T1DM, preceding hypertension and nephropathy. Early intervention to 
restore pressure natriuresis in T1DM may complement reductions in cardiovascular risk achieved 
with glycaemic control.   
Keywords: hypertension, blood pressure, pressure natriuresis, experimental type 1 diabetes 
mellitus, sodium homeostasis, lithium clearance 
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Introduction 
Type 1 diabetes mellitus (T1DM), the common form of diabetes in children and adolescents, 
increases cardiovascular risk ~5 fold (Rawshani et al., 2017). Hypertension and albuminuria, more 
prevalent in T1DM patients than the general population, are major risk factors in this increased 
burden of cardiovascular disease (de Ferranti et al., 2014) and are interrelated: high blood pressure 
(BP) accelerates the development of diabetic nephropathy (Conway et al., 2012); and nephropathy 
impairs the ability of the kidney to stabilise BP. Hypertension treatment reduces the risk of 
nephropathy (Shankar et al., 2007) and improves cardiovascular outcome in T1DM (Rawshani et al., 
2017).  
The kidneys play an important role in long-term BP homeostasis, regulating the effective circulating 
volume through the excretion of sodium chloride. There is a strong positive relationship between 
arterial pressure, renal perfusion pressure and sodium excretion, termed the pressure natriuresis 
(PN) response (Ivy & Bailey, 2014). Thus, an acute increase in BP evokes a corresponding increase in 
blood flow through the renal medullary vasa recta, increasing renal interstitial hydrostatic pressure, 
which, in turn, inhibits sodium reabsorption in the renal tubule through a combination of physical 
factors (Starling forces) and paracrine signalling (Ivy & Bailey, 2014). Natriuresis predominantly 
reflects reduced reabsorption in the proximal tubule, following functional inactivation of major 
sodium transport proteins. Thus, the sodium-hydrogen exchanger, NHE3, is redistributed to the base 
of microvilli in the apical brush-border membrane and inactivated (Brasen et al., 2014); the sodium-
phosphate cotransporter, NaPi2, is removed from the brush border and internalized in endosomes 
(Riquier et al., 2009). Such a significant reduction in proximal tubule reabsorption increases sodium 
delivery to downstream nephron segments, which normally stimulate the reabsorption of sodium. 
However, the PN response is integrated so that paracrine factors, such as nitric oxide (NO (O'Connor 
& Cowley, 2010) and ATP (Menzies et al., 2015), suppress compensatory reabsorption in the distal 
nephron. Intrinsic renal abnormalities (vascular dysfunction; enhanced tubular reabsorption) and 
extra-renal factors (sympathetic over-activity, non-modulating renin-angiotensin-aldosterone system 
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(RAAS), interstitial inflammation) blunt the PN relationship, as observed in both human and 
experimental hypertension (Wadei & Textor, 2012; Hall, 2016).  
We hypothesised that the PN response would be impaired early in T1DM, manifesting as an 
increased BP.  Direct measurement of the PN relationship did, indeed, reveal substantial suppression 
of the PN curve in rats with uncomplicated T1DM.  Although systolic BP was normal in these rats, 
diastolic BP was elevated and the normal dipping in diastolic BP during sleep was reduced.  
 
Methods 
Ethical Approval  
Experiments were performed in accordance with the UK’s Animals (Scientific Procedures) Act under 
a UK Home Office Project Licence. All protocols were reviewed by the University’s Animal Welfare 
and Ethics Review Board prior to experimentation (357-LF2-16 and 381-LF2-18), and these 
experiments conform to the principles and regulations described in The Journal’s Editorial (Grundy, 
2015).   
Origin and source of animals and husbandry 
Adult male Sprague Dawley rats, weighing 250-300g, were purchased from Charles River UK, and 
transported to Edinburgh under conditions specified in the UK’s Animal Welfare Act, 2006. Rats were 
maintained on standard chow (0.25% sodium) and water ad libitum, and were housed in rooms with 
a 12-hour light cycle (lights 7am-7pm) at 21±1ºC and 50% humidity. In total, 108 rats were used in 
this study. Rats underwent euthanasia by an ASPA-defined Schedule 1 method prior to study 
completion if they developed adverse effects associated with T1DM (n=6), failed to become diabetic 
(n=1) or if radiotelemetry devices malfunctioned (n=4). Experiments, assays and histological scoring 
were performed with the operator blind to treatment group.  
Induction of T1DM 
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T1DM was induced by injection of streptozotocin (STZ; 50mg/mL in 0.1M citrate buffer, IP; Sigma-
Aldrich, UK). All rats received an initial dose of 30mg/kg and blood glucose was measured after 48h 
using a glucometer (Accu-Chek Aviva; Roche Diagnostics Limited, Burgess Hill, UK). A blood glucose 
of >12mmol/l was required to confirm T1DM; some rats did not reach this threshold and a second 
injection of 15mg/kg was then given. Blood glucose was again measured at Day 7 and at the end of 
the experimental procedure to confirm sustained hyperglycaemia. Non-diabetic control rats received 
vehicle alone. In one group of T1DM rats, blood glucose was controlled to <12mmol/l by a slow-
release insulin pellet (LinShin, Toronto, Canada) implanted subcutaneously seven days after 
confirmation of T1DM.  All experiments were performed two-to-three weeks after the final STZ 
injection.   
Measurement of PN and Renal Blood Flow 
Experiments were performed under non-recovery anaesthesia (Thiopental; 50mg/kg i.p.; 
Archimedes Pharma, Reading, UK). The right jugular vein was cannulated for intravenous infusion of 
physiological saline (pH 7.4; 1ml/h/100gbw) containing 2% (w:v) bovine serum albumin, to limit 
extravasation, and FITC-inulin, for measurement of glomerular filtration rate (GFR). General 
anaesthesia was also maintained through this line by 20-30l injections of 50mg/ml sodium 
thiopental. A tracheotomy was performed and the right carotid artery cannulated with p50 
polyethylene tubing (Smiths Medical International Ltd, Hythe, UK) pre-flushed with heparinised 
saline. The arterial line was used for intermittent blood sampling and otherwise was connected to a 
calibrated BP transducer and multi-channel data acquisition system (Powerlab; ADInstruments, 
Oxford, UK) for real-time BP measurement. 
In the first experiment, after a post-surgical equilibration period of ~60 minutes, baseline BP, urine 
flow rate, urinary sodium excretion rate and GFR were measured over a 30-minute period in T1DM 
and non-diabetic control rats (Table 1). PN was then induced by sequential arterial ligation of, first, 
the coeliac and cranial mesenteric arteries, and, second, the distal aorta, as described (Roman et al., 
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1988; Menzies et al., 2013), and, after each step of increased BP, urine was collected for 30 minutes.  
For the second and subsequent PN experiments, PN was measured in T1DM and non-diabetic 
controls but with an additional insulin-treated diabetic group (T1DM+insulin; Table 1).  
In the third PN experiment, left renal artery blood flow was measured during PN by Doppler 
ultrasound, and cortical and medullary flow by Doppler flux (Stern et al., 1979). To do this, a 
calibrated Doppler ultrasound probe (PR-probe; Transonic, Ithaca, USA) was placed around the left 
renal artery and ultrasound gel was used for acoustic coupling. The probe was gently rotated to 
optimise the signal, as visualised by real-time pulse-wave recordings, and then the probe was left in 
place to record renal artery blood flow (RBF; ml/min). Renal cortical and medullary blood flows were 
estimated by laser Doppler spectroscopy obtained via two separate probes. A patch probe 
(MSP100XP; ADInstruments) was connected to the dorsal renal surface using tissue glue (Vetbond; 
3M, UK) to obtain readings from the cortex; a needle (MNP110XP; ADInstruments) probe was 
inserted through the capsule to a depth of ~5mm, orientated toward the renal hilus. This positioned 
the probe in the outer medulla, confirmed at post mortem. This probe was stabilised using a 
micromanipulator and tissue glue was used to further dampen respiratory motion artefact. Doppler 
spectroscopy infers red blood cell velocity by the frequency modulation of reflected laser light. This 
Doppler shift is proportional to cell velocity but since the angle of the capillary and the exact 
concentration of erythrocytes is unknown, an absolute velocity cannot be determined. Instead, data 
are presented as flux, measured in arbitrary perfusion units, presented relative to the baseline 
recording of an individual rat (Stern et al., 1979).  
During the fourth and final PN experiment, rats were infused with a solution containing 10mmol/l 
lithium chloride (replacing sodium chloride) to allow measurement of lithium clearance, which 
provides an index of proximal tubule sodium and water reabsorption, as described (Thomsen & 
Shirley, 1997).  
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Assessment of renal injury and sodium transporter mRNA abundance 
A 24-hour urine collection was made from T1DM, T1DM+insulin and non-diabetic control rats (Table 
2) two weeks after induction of T1DM. The urine concentration of aldosterone was measured using 
an in-house ELISA, the specificity and sensitivity of which is described (Al-Dujaili et al., 2009). Urine 
albumin (Microalbumin kit; Olympus Diagnostics, Watford, UK) and creatinine (Alpha Laboratories, 
Eastleigh, UK) were measured on a Cobas Fara centrifugal analyser (Roche Diagnostics Limited). Rats 
then underwent euthanasia, the left kidney was removed, and sections of cortex and medulla snap-
frozen for mRNA extraction. Following perfusion-fixation (4% paraformaldehyde), the right kidney 
was paraffin-embedded, sectioned (5µm) and stained with haematoxylin and eosin (to score 
glomerulosclerosis (Rodriguez-Iturbe et al., 2005)) and the pan-collagen marker, picrosirius red (to 
score fibrosis). Scoring was performed blinded to group under a 20x objective lens (Conway et al., 
2012). 
Quantitative RT-PCR was used to measure the renal abundance of mRNA for genes associated with 
renal injury/inflammation (Havcr1, Col1a1, Col3a1 and CD68) and those encoding major sodium 
transporters (Na,K-ATPase α and β subunits, NHE3, SGLT2, NKCC2, NCC and ENaC). Expression was 
determined using validated TaqMan probes (ThermoFisher Scientific Inc, Glasgow, UK).  Following 
amplification of cDNA, fluorescence of the FAM probes was compared to reference genes GAPDH 
and TBP using the change in threshold cycle (ΔCT) method (Schmittgen & Livak, 2008). 
BP measurement in conscious rats 
Radiotelemetry devices (TA11-CA P40; Data Sciences International, Hertogenbosch, Netherlands) 
were implanted into eight male Sprague Dawley rats under anaesthesia (inhalational isoflurane, 
IsoFlo; Zoetis Animal Health Ltd., Sandwich, UK) using aseptic technique. The sensor tip was fixed 
into the abdominal aorta, and, after surgery, rats were placed on an insulated mat in a recovery box 
heated by warm airflow. Post recovery, rats were monitored for a period of at least one hour, and 
then transferred to individual cages in the radiotelemetry room. Rats received buprenorphine 
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(0.5mg/kg s.c.; Buprecare; Animalcare, York, UK) every 12 hours for three days. Systolic BP (SBP), 
diastolic BP (DBP) and heart rate were acquired over several days to confirm restoration of normal 
diurnal rhythms. Devices were then turned off using a strong magnet placed over the skin, and rats 
were randomly allocated to T1DM or non-diabetic treatment groups (Table 2). The devices were 
turned on, and data acquired during the fourth week after the first streptozotocin injection.  Data 
were acquired at 1kHz over a 1-minute period in every hour in T1DM and control rats. Zeitgeber 
time zero (ZT=0) was defined as the start of the dark period at local time 7pm.  Diurnal dipping was 
calculated for every rat during every day as the % reduction in the mean heart rate, mean SBP and 
mean DBP in the light period compared to the previous dark period.  At the end of the experiment, 
rats underwent euthanasia by CO2 asphyxiation followed by cervical dislocation.  
Statistical Analysis 
Data are expressed as mean ± standard error of the mean (SEM) and analysed with Minitab 17 
(Minitab Ltd, Coventry, UK) and GraphPad Prism 6.0 (GraphPad Software, La Jolla, USA).  Non-
normal data (Anderson-Darling test) were compared following log or square-root 
transformation, or using non-parametric tests.  For PN studies, two-way ANOVA with Holm-
Sidak’s (two groups) or Tukey’s (three groups) post hoc tests confirmed similar baseline MBP 
and increments (independent variable) between groups.  Dependent variables were similarly 
compared, and interaction between diabetic status and clearance period was calculated.  As 
additional analysis, dependent variables were plotted against BP and regression lines compared 
by analysis of covariance (ANCOVA) with Tukey post hoc tests (linear) and extra sum of squares 
F-tests (nonlinear).  Correlations between dependent variables used Pearson’s (normal) or 
Spearman’s rank (non-normal) tests.  For radiotelemetry and assessment of renal injury, single 
comparisons between groups were made with two-sample t-tests (normal) or Mann Whitney U-
tests (non-normal), while multiple comparisons employed one-way ANOVA with Tukey post hoc 
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tests (normal) or Kruskal Wallis with Dunn’s post hoc tests (non-normal).  For all tests, statistical 
significance was set at P<0.05. 
Results 
T1DM impairs the Pressure Natriuresis Response 
Serial arterial ligation was used to impose an acute increase in BP and induce the PN response in 
non-diabetic control rats (Table 1). Arterial ligation increased BP by ~25mmHg (Figure 1A), and 
significantly increased GFR (Figure 1B; P<0.01) and, therefore, the filtered sodium load.  However, 
the robust diuresis (Figures 1C & 1D; P<0.01) and natriuresis (Figures 1E & 1F; P<0.01) that were 
induced were accompanied by a rise in fractional excretion of sodium (FENa) from ~1% at baseline to 
~25% at peak perfusion pressure (Figures 1G & 1H; P<0.01), indicating a substantial inhibition of 
tubular sodium reabsorption during PN. After three weeks of diabetes, rats in the T1DM group had 
similar BP at baseline and during each of the pressure-ramps (Figure 1A) but the renal response was 
very different from non-diabetic control animals. The maximum absolute diuresis (Figures 1C & 1D) 
and natriuresis (Figures 1E & F) were suppressed by ~80% (both P<0.01).  The increase in GFR was 
also blunted, but only by ~0.2ml/min/g kw (Figure 1B; P=0.01). FENa was significantly lower at 
baseline in T1DM rats at ~0.5% (P<0.01) and increased to only ~3% at peak perfusion pressure 
(Figures 1G & 1H). 
Effect of insulin treatment on the pressure natriuresis response 
PN was next measured in three groups of rats: non-diabetic controls, T1DM, and insulin-treated 
T1DM. Insulin therapy significantly reduced plasma glucose compared to untreated T1DM rats, 
although it remained higher than in non-diabetic control animals (Table 1). Baseline BP did not differ 
between the three groups, and sequential arterial ligation again induced significant increments, 
totalling ~35mmHg, that did not differ between groups (Figure 2A). GFR (Figure 2B), urine flow 
(Figures 2C & 2D), sodium excretion (Figures 2E & 2F), and FENa (Figures 2G & 2H) increased 
significantly with BP in all three groups, and the maximum responses were again suppressed in 
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T1DM rats, by up to 60% (all P≤0.02). Chronic insulin-treatment of diabetic rats effectively restored 
these relationships to control levels. Indeed, the slopes of the pressure-diuresis (Figure 2D) and PN 
(Figure 2F) responses were not significantly different between non-diabetic control and insulin-
treated diabetic rats. By contrast, in the untreated T1DM group, the slopes of these relationships 
were, in each case, significantly blunted (P<0.01; Figures 2D & 2F), despite GFR being unaffected by 
diabetic status (Figure 2B), suggesting that impaired PN reflects diabetes, rather than an off-target 
effect of STZ.  
Mechanism of impaired PN in T1DM: renal haemodynamics 
RBF and perfusion of the renal cortex and medulla, were measured at baseline and during sequential 
arterial ligation (Table 1). RBF (Figure 3A) was not different between groups at baseline and did not 
change significantly with increased BP, suggesting effective autoregulation.  Perfusion of the cortex 
and medulla was measured by Doppler flux and, for group comparison, baseline recordings were 
normalised to 100%.  Cortical flux did not change with increased BP in non-diabetic rats, falling 
slightly, but not significantly in T1DM and insulin-treated groups at the highest perfusion pressure 
(Figure 3B).  In non-diabetic control rats, perfusion of the medulla increased significantly with 
arterial pressure (Figure 3C).   However, this pressure dependence of medullary flux was not 
observed in T1DM rats. Importantly, insulin therapy, which had restored the natriuretic response to 
increased BP (Figures 2E & 2F), did not restore the pressure dependence of medullary blood flow in 
T1DM rats (Figure 3C).  
Mechanism of impaired PN in T1DM: tubular sodium reabsorption 
In the final PN experiment, we determined the effect of increasing BP on the renal lithium clearance 
(CLi) in additional rats in the same three groups (Table 1).  As before, sequential arterial ligation 
significantly increased BP in all three groups of rats (P<0.01), here by an average of ~25mmHg 
(Figure 4A).  Sodium excretion increased with BP (P<0.01) and was again lower in T1DM rats than in 
the other two groups, but, with peak BP ~10-20mmHg lower than in the previous PN experiments, 
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this did not reach statistical significance (Figure 4B).  At baseline BP, neither T1DM (0.04±0.01 
ml/min/gkw) nor T1DM+insulin (0.08±0.01 ml/min/gkw) affected CLi (control, 0.08±0.01 
ml/min/gkw), while increasing BP led to a similar significant increase in CLi in all three groups (Figure 
4C; P<0.01).   
T1DM did not induce renal injury or changes in major sodium transporter expression. 
Renal injury was assessed at the three-week time point. In T1DM rats, the urinary albumin:creatinine 
ratio was ~1.6 fold greater than that of non-diabetic control rats (P=0.02) but we could not detect 
glomerulosclerosis on histopathological assessment.  Picrosirius red staining was used to report 
collagen abundance and this did not differ between groups in either the renal cortex (T1DM 
0.52±0.08% vs control 0.41±0.02%) or medulla (T1DM 0.29±0.03% vs control 0.36±0.03%). 
Transcriptional markers that are sensitive to renal injury, Havcr1, Col1a1, Col4a1 and CD68, were 
measured in the renal cortex and medulla and were not different between groups.  We found no 
change in the mRNA abundance of the major renal sodium transporter proteins (Na,K-ATPase α and 
β subunits, NHE3, SGLT2, NKCC2, NCC and ENaC), and the urinary:aldosterone creatinine ratio, 
indicative of RAAS activity, was not different between groups (data not shown). 
T1DM increases diastolic blood pressure and impairs dipping 
Finally, we determined whether the impaired PN response in uncomplicated T1DM was associated 
with an increased BP. Radiotelemetry probes were implanted into T1DM and non-diabetic rats 
(Table 2), permitting longitudinal recording of SBP, DBP and heart rate in conscious, unrestrained 
animals.  After three weeks of diabetes, SBP (Figure 5A) was comparable to control animals and also 
displayed normal diurnal variation (Table 3), as assessed by both calculating the dip in SBP from dark 
(active) to light (sleep) periods, and by using cosinor analysis to generate mesor (as the central 
tendency), the amplitude of the diurnal variation and the acrophase of the 24-hour cycle.  
By contrast, mean DBP was increased in T1DM rats by ~5mmHg (P<0.01), and the normal diurnal 
variation was suppressed such that the dip in diastolic BP during the light phase was reduced by 4% 
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(Table 3; Figure 5B; P<0.01), reflected also in a significant reduction in the cyclic amplitude (P=0.04, 
Table 3).  Heart rate was less in T1DM rats by ~20 beats/min (Table 3; Figure 5C; P<0.01) but 
displayed normal diurnal variation in both groups. 
 
Discussion 
PN is the integrated tubulovascular response to increased renal perfusion pressure (Ivy & Bailey, 
2014).  It is thought to stabilise long-term BP at a given set-point (Guyton, 1987), and functional 
impairment is considered an important early event leading to the development of hypertension 
(Wadei & Textor, 2012; Hall, 2016). In established hypertension, the PN curve is suppressed/right-
shifted (DeClue et al., 1978; Norman et al., 1978; Kimura et al., 1987). This abnormal BP homeostasis 
manifests initially as attenuation or loss of the normal nocturnal BP dip (Fukuda et al., 2012). 
Normally, elevated renal arterial perfusion pressure induces a PN response consisting of both 
haemodynamic and tubular components.  Here, we show in anaesthetised rats that uncomplicated 
T1DM substantially blunts both components: (i) blood flow in the renal medulla is uncoupled from 
arterial pressure and (ii) sodium transport through the tubule epithelium fails to down-regulate with 
increased perfusion pressure. In non-diabetic rats, the applied pressure ramps increased GFR and 
the filtered sodium load, elevated blood flow in the renal medulla, and reduced tubular sodium 
reabsorption. T1DM affected all elements of the PN response: increases in GFR and medullary blood 
flow were blunted, while tubular sodium reabsorption did not decrease substantially.  
We do not consider the lack of pressure-induced hyperfiltration to be a major factor in the blunted 
natriuresis observed in T1DM rats: even in healthy rats, GFR does not consistently increase during 
PN and in vivo micropuncture studies show that single nephron GFR is largely autoregulated across 
the range of pressure used here (Haas et al., 1986; Roman et al., 1988). Thus, the contribution of 
increased filtration to the overall natriuretic response is likely to be small, even in the non-diabetic 
controls.  Similar findings are reported in patients with uncomplicated T1DM.  They exhibit a blunted 
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natriuretic response to saline infusion (Roland et al., 1986) or water immersion (O'Hare et al., 1989), 
also attributed to avid renal sodium retention, while maintaining or even increasing creatinine 
clearance, a clinical marker of GFR.  Furthermore, we do not believe that structural nephropathy 
contributed to impaired PN in T1DM rats, since we found no evidence of renal injury by histological, 
biochemical or sensitive molecular approaches.  
Of greater biological significance is the uncoupling of medullary flux from arterial pressure in T1DM 
rats. Increased blood flow through the vasa recta causes interstitial pressure to rise throughout the 
kidney (Garcia-Estan & Roman, 1989) and is widely held to be a key process for PN (Roman et al., 
1988; O'Connor & Cowley, 2010).  The pressure dependence of renal medullary flux was attenuated 
in T1DM rats. It could be speculated that such vascular dysfunction reflects reduced bioavailability of 
NO (Pflueger et al., 1999; Persson et al., 2017), an important mediator of the rise in vasa recta blood 
flow and the PN response (Lockhart et al., 1994). Indeed, T1DM impairs the normal hyperaemic 
response of the vasa recta to NO (Palm et al., 2005; Persson et al., 2014) and alterations in both NO 
production and vascular sensitivity would be expected to uncouple medullary flux from arterial 
pressure. Such haemodynamic uncoupling has been suggested by earlier experiments in which early 
T1DM diminished the rise in renal interstitial hydrostatic pressure following an acute saline load 
(Patel & Carmines, 2001). Surprisingly, we found that restoring normal blood glucose levels with 
insulin normalised the PN curve without re-coupling medullary flux to arterial pressure. This 
unanticipated finding is consistent with the restoration of the natriuretic response to a saline load 
that occurs in pregnant diabetic rats, despite continued suppression of renal interstitial pressure 
(Tang et al., 2004), and challenges the prevailing view that medullary hyperaemia is an essential 
component of the PN response. 
It is well established that T1DM increases basal tubular sodium reabsorption, as we report here. In 
terms of molecular mechanism, some studies (Ward et al., 2001; Song et al., 2003) report 
increased expression of NHE3 (proximal tubule), NKCC2, (Loop of Henle), NCC (distal convoluted 
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tubule) and ENaC (collecting duct) in T1DM rats but this is not a consistent finding (Nejsum et al., 
2001). In our study, T1DM did not increase the mRNA expression of these sodium transporters, and 
we therefore utilised CLi to localise the tubular defect in T1DM rats. The central tenets of the CLi 
approach are that lithium is reabsorbed in the proximal tubule in direct proportion to sodium and 
water but is not reabsorbed in the loop of Henle and the distal nephron.  Micropuncture studies in 
rodents indicate that the CLi approach is less accurate in some disease settings, including T1DM 
(Pollock & Field, 1992), but nevertheless it remains a valuable qualitative marker of proximal tubule 
function (Thomsen & Shirley, 1997). Our data clearly show that CLi increases with BP to a similar 
extent in both T1DM and non-diabetic rats. Thus, the proximal tubule modulates appropriately in 
T1DM rats within a mean BP range of ~90-130mmHg, and the tubular defect accounting for an 
impaired PN response in early T1DM is in the distal nephron.  
The identification of the causative physiological mechanism is an important step towards defining 
the underpinning molecular pathways of impaired PN. It is possible that an individual transport 
system in the loop of Henle, distal convoluted tubule or collecting duct fails to turn off as perfusion 
pressure rises. Against this hypothesis is the restoration of the natriuretic response by insulin 
therapy demonstrated here, since insulin activates sodium transporter pathways (Komers et al., 
2012; Mansley et al., 2016).  A more compelling speculation is that an inhibitory paracrine pathway 
fails to respond to increased BP, and distal sodium reabsorption is sustained rather than integrated 
into the overall natriuretic response. NO, discussed above, is an attractive potential candidate. 
Another candidate is ATP, which is normally released in response to increased renal perfusion 
pressure (Palygin et al., 2017) and inhibits tubular sodium transport through ENaC (Menzies et al., 
2015). Notably, genetic deletion of connexin 30 (Sipos et al., 2009), which mediates ATP release in 
the distal tubule (Palygin et al., 2017), impairs the PN response in mice.  
Studies in patients show that sodium retention occurs early in T1DM, correlating positively with BP 
(Feldt-Rasmussen et al., 1987). Our data suggest that restoration of PN may help improve long-term 
sodium homeostasis in patients with T1DM but the study does not establish a direct and causal 
 This article is protected by copyright. All rights reserved. 
relationship between loss of the acute PN response and hypertension. Indeed, whether a causal 
relationship exists is a current controversy in cardiovascular research. The Guytonian hypothesis 
remains influential (Hall, 2016) but other authorities, while acknowledging that renal excretory 
impairment is a sine qua non for hypertension, argue for a new paradigm (Evans & Bie, 2016). 
Indeed, several studies, including from our laboratory (Evans et al., 2016), show salt-sensitive 
hypertension in the absence of demonstrably impaired renal function, most likely reflecting an 
abnormal vasodilatory response to effective circulatory volume expansion and increased cardiac 
output (see (Morris et al., 2016) for review). Here, we report both vascular and tubular dysfunction 
in T1DM rats. These animals were not hypertensive per se but the mean 24-hour DBP was increased 
by ~5mmHg, which could not be explained on the basis of tachycardia, since heart rate was 
consistently less than in controls.  Ambulatory BP monitoring also revealed a reduction in diastolic 
dipping during the sleep phase of the diurnal cycle. In T1DM patients, reduced BP dipping and an 
increase in daytime DBP but not SBP, precedes and predicts the onset of albuminuria (Lurbe et al., 
2002). Non-modulating sodium transport may be causal such that elevated nocturnal BP is required 
to facilitate sodium excretion and restore balance (Bankir et al., 2008) but at the expense of 
glomerular exposure to prolonged haemodynamic stress.  In a wider context, there is some evidence 
that therapeutic restoration of BP rhythm reduces cardiovascular risk (Hermida et al., 2018) and our 
work raises the possibility that impairment of PN may be a suitable therapeutic target for reducing 
cardiovascular risk in T1DM before structural nephropathy develops.   
Conclusion 
We conclude that PN is impaired at an early stage of T1DM, prior to the onset of nephropathy and 
contemporaneous with increased DBP and loss of diastolic dip. We propose that such impairment is 
an important event in the progression of T1DM, rendering BP homeostasis vulnerable to a “second 
hit”, such as habitually high salt intake (Gray et al., 2014). Early intervention to restore the normal 
relationship between arterial pressure and tubular sodium reabsorption could have long-term 
benefits for renal and cardiovascular risk in T1DM.  
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Translational Perspective 
We hypothesised that the pressure natriuresis response (PN) is impaired early in type 1 diabetes 
mellitus (T1DM), manifesting as an increased blood pressure (BP). Our data demonstrate that there 
is a severe, hyperglycaemia-dependent impairment of PN in early T1DM that is normalised by 
insulin, and occurs before the development of structural nephropathy.  It is not associated with 
systolic hypertension, but, instead, with an increased mean diastolic BP and decreased diastolic 
dipping of BP that are analogous to the increase in daytime diastolic BP observed in T1DM patients 
prior to nephropathy (Lurbe et al., 2002).  These findings are consistent with, first, reductions in 
cardiovascular risk observed with tight blood glucose control in clinical T1DM (Nathan et al., 
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications 
Study Research Group 2005), and, second, changes in BP that predict nephropathy in T1DM (Lurbe 
et al., 2002).  Clinically, tight blood glucose control achieves maximal reductions in cardiovascular 
risk within a crucial early window after diagnosis of T1DM (Nathan et al., Diabetes Control and 
Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research 
Group 2005).  However, as T1DM is most frequently diagnosed in young children, this approach 
increases the risk of life-threatening hypoglycaemia.  We have identified impaired PN as a potential 
target for cardiovascular protection in early T1DM that may complement insulin therapy, especially 
where tight blood glucose control is not achieved or practicable.    
(230 words) 
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Figure 1.  Pressure natriuresis in diabetic and non-diabetic control rats 
(A) Baseline mean blood pressure (BP) and increments following arterial ligation in diabetic (T1DM, 
black bars) and non-diabetic controls (open bars).  Columns show mean ± standard error of the 
mean (SEM), *=P<0.05 compared with mean BP in previous period, NS=not significant.   
Panels (B) to (E) show the relationships between BP and (B) glomerular filtration rate, (C & D) urine 
flow rate, (E & F) urinary sodium excretion rate (all indexed to kidney weight) and (G & H) fractional 
excretion of sodium in T1DM rats (closed circles) and non-diabetic control rats (open circles). Data 
are mean ± SEM. **=P<0.01 compared with controls 
All comparisons made with two-way analysis of variance (ANOVA) with Holm-Sidak’s post hoc tests.  
Regression lines compared by analysis of covariance (ANCOVA) with Tukey’s post hoc tests (linear) 
and extra sum of squares F-tests (nonlinear).  R2=coefficient of determination.  Main effects are 
described in the text. 
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Figure 2.  Pressure natriuresis in control, diabetic (T1DM) and insulin-treated diabetic 
(T1DM+insulin) rats 
(A) Baseline mean blood pressure (BP) and increments following arterial ligation in diabetic (T1DM, 
black bars), insulin-treated diabetic rats (T1DM+insulin, grey bars) and non-diabetic control rats 
(open bars). Columns show mean ± standard error of the mean (SEM), *=P<0.05 compared with 
mean BP in previous period, NS=not significant.   
Panels (B) to (E) show the relationships between BP and (B) glomerular filtration rate, (C & D) urine 
flow rate, (E & F) urinary sodium excretion rate (all indexed to kidney weight) and (G & H) fractional 
excretion of sodium in T1DM rats (closed circles), insulin-treated T1DM+insulin rats (grey squares) 
and non-diabetic control rats (open circles). Data are mean ± SEM. **=P<0.01 compared with 
controls and *=P<0.01 compared with T1DM. 
All comparisons made with two-way analysis of variance (ANOVA) with Tukey’s post hoc tests.  
Regression lines compared by analysis of covariance (ANCOVA) with Tukey’s post hoc tests. 
R2=coefficient of determination.  Main effects are described in the text. 
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Figure 3.  The relationship between arterial pressure and renal haemodynamics 
The relationship between arterial blood pressure and (A) left renal artery blood flow, (B) perfusion of 
the renal cortex, and (C) perfusion of the renal medulla in diabetic rats (T1DM, closed circles), 
insulin-treated diabetic rats (T1DM+insulin, grey squares) and non-diabetic control rats (open 
circles). Data are mean ± standard error of the mean (SEM). **=P<0.01 compared with T1DM only, 
and *=P<0.01 compared with either T1DM or T1DM+insulin, using two-way analysis of variance 
(ANOVA) and Tukey’s post hoc tests.  Main effects are described in the text 
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Figure 4. Lithium clearance in control, diabetic and insulin-treated diabetic rats  
(A) Baseline mean blood pressure (BP) and increments following arterial ligation in diabetic (T1DM, 
black bars), insulin-treated diabetic rats (T1DM+insulin, grey bars) and non-diabetic control rats 
(open bars). Columns show mean ± standard error of the mean (SEM), *=P<0.05 compared with 
mean BP in previous period, NS=not significant.   
Panels (B & C) show the relationships between BP and (B) urinary sodium excretion rate and (C) 
lithium excretion (both indexed to kidney weight) in T1DM rats (closed circles), insulin-treated 
T1DM+insulin rats (grey squares) and non-diabetic control rats (open circles). Data are mean ± SEM.  
All comparisons made with two-way analysis of variance (ANOVA) with Tukey’s post hoc tests.  Main 
effects are described in the text. 
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Figure 5. Blood pressure and heart rate 
Blood pressure and heart rate were measured by radiotelemetry every hour over five days in 
diabetic (T1DM) rats (closed circles) and non-diabetic control rats (open circles). Zeitgeber time zero 
is the start of the dark period (black bar), the open bar is the light period.  Data points are group 
mean ± standard error of the mean (SEM) over a 24-hour cycle.  (A) systolic blood pressure; (B) 
diastolic blood pressure; and (C) heart rate. **=P<0.05 for mean value over 24 hours in diabetic rats 
compared with controls, using two-sample Student’s t- or Mann Whitney U-tests according to 
normality of data.  Main effects are described in the text. 
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Table 1. Number, weight, blood glucose (BG) prior to anaesthesia, and mean blood 
pressures (BP) of control, diabetic (T1DM) and insulin-treated (T1DM+insulin) rats, during 
ligature-induced acute pressure natriuresis 
Data are mean ± standard error of the mean (SEM), **=P<0.05 compared with controls, *=P<0.05 
compared with diabetics.  All comparisons made with two-sample Student’s t-tests or one-way 
analysis of variance (ANOVA) with Holm-Sidak’s or Tukey’s post hoc tests. 
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Table 2. Number, weight and blood glucose (BG) of control and diabetic (T1DM) rats that 
completed the radiotelemetry (RT) study, and control, T1DM and insulin-treated diabetic 
rats used in renal injury (RI) studies.   
Data are mean ± standard error of the mean (SEM), **=P<0.05 compared with controls, *=P<0.05 
compared with diabetics.  All comparisons made with two-sample Student’s t-tests or one-way 
analysis of variance (ANOVA) with Tukey’s post hoc tests. 
 RT 
STUDIES 
Start Finish 
RI 
STUDIES 
   
 
Contr
ol 
T1DM 
Contro
l 
T1DM  Control T1DM 
T1DM+ins
ulin 
Numbe
r 
    4            4  4            4 Number 8 8 8 
Weight 
(g) 
331±4 
     
317±3** 
586±11 
     
477±23** 
Weight 
(g) 
  
383.8±7.7 
359.5±1
2.4 
    
372.7±13.
0 
BG 
(mmol/
L) 
   
4.4±0.
3 
   
18.7±1.8
** 
  
5.1±0.3 
  
19.5±1.1
** 
BG 
(mmol/L) 
6.8±0.3 
    
22.0±3.0
** 
      
10.5±0.9* 
 
  
 This article is protected by copyright. All rights reserved. 
Table 3. Means, dips and cosinor analysis values for blood pressure and heart rate  
Data were recorded by radiotelemetry in diabetic (T1DM; n=4) rats and non-diabetic controls (n=4), 
and are expressed as mean ± standard error of the mean (SEM). **=P<0.05 compared with controls, 
using two-sample Student’s t-tests for means and dips, and Welch’s t-test for cosinor analysis.  
SBP, systolic blood pressure; DBP, diastolic blood pressure; bpm, beats per minute; Amp, amplitude; 
Acro, acrophase. 
 
 SBP DBP Heart rate 
 
Control   T1DM Control T1DM  Control     T1DM 
Mean 
(mmHg/bpm) 
126.2±0.5 126.5±0.4 92.2±0.4 97.1±0.4** 361.7±2.5 341.5±2.3** 
Dip 
(%) 
    3±1     3±1   6±1   2±1** 15±1       12±1 
Mesor 
(mmHg/bpm) 
127.4±2.9 126.5±1.1 91.4±1.2 94.0±2.7 362.3±11.1 336.7±17.5 
Amp 
(mmHg/bpm) 
    2.9±0.5     3.1±0.3   4.1±0.4 1.8±0.7** 45.8±4.5 35.4±3.8 
Acro 
(radians) 
  69.3±4.4   71.3±1.7 81.6±2.9 46.2±15.8 71.1±2.6 76.6±6.8 
 
 
 
